NCT00822614

Safety of Fentanyl TAIFUN Treatment

The Safety of Fentanyl TAIFUN Treatment After Titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Akela Pharma, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate hte Safety of Fentanyl TAIFUN Treatment after titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy

Conditions

• Breakthrough Cancer Pain

Interventions

Type	Name	Description
DRUG	Fentanyl TAIFUN	Inhalation of Fentanyl via TAIFUN inhaler
DRUG	Opioid	Current optimized BTP treatment

Timeline

• Start date: 2008-12-01
• Primary completion: 2009-12-01
• Completion: 2010-01-01
• First posted: 2009-01-14
• Last updated: 2009-01-14

Locations

1 site across 1 country: Poland